Desarrollo de nuevas estrategias de inmunoterapia

INFORMACIÓN DE CONTACTO
Foto Equipo
Grupo de Investigación

LASARTE SAGASTIBELZA, JUAN JOSE
  Correo Electrónico jjlasarte@unav.es


Foto Grupo

ARDAIZ IRIARTE, NURIA
BELSUE URQUIZU, VIRGINA
Repáraz, D, Casares, N, Fuentes, A, Navarro, F "Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment".
 Methods Cell Biol.. 185: 79 - 97. 2024. [doi:10.1016/bs.mcb.2024.02.006]
Arrizabalaga, L, Di Trani, CA, Risson, A, Belsúe, V, Gomar, C, Ardaiz, N, Berrondo, P, Aranda, F, Bella, A "Peritoneal carcinomatosis in mouse models".
 Methods Cell Biol.. 185: 67 - 78. 2024. [doi:10.1016/bs.mcb.2024.02.005]
Aparicio, B, Silva, L, Ruiz, M, Llópiz, D, Repáraz, D, Theunissen, P, Tamayo, I, Egea, J, Igea, A, Smerdou, C, Peñas, M, Perpiñá, C, Matilla, A, Varela, M, Reig, M, de la Torre-alaez, M, Argemí, J, Sangro, B, Hervás-Stubbs, S, Sarobe, P "Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy".
 OncoImmunology. 15(1): 2645280. 2026. [doi:10.1080/2162402X.2026.2645280]
imagen
Armero, M, Smolkin, M, Garcia-Dominguez, M, Berraondo, P, Melero, I, Galvez-Cancino, F "Facts and Hopes in Harnessing Macrophage-Mediated Antibody-Dependent Cellular Phagocytosis for Cancer Immunotherapy".
 Clin. Cancer Res.. 32(3): 455 - 464. 2026. [doi:10.1158/1078-0432.CCR-25-0434]
Salgado-Pascual, A, Zalba, S, Lasarte, JJ, Garrido, MJ "Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape".
 Adv. Drug Deliv. Rev.. 229: 115760 - 115760. 2026. [doi:10.1016/j.addr.2025.115760]
Bunuales, M, Inoges, S, de Cerio, ALD, Hervas-Stubbs, S, Rodriguez, J, Gonzalez-Aparicio, M, Jauregui, P, Hernandez-Alcoceba, R "Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer".
 Gene Ther.. . 2026. [doi:10.1038/s41434-025-00590-1]
Arrizabalaga, L, Di Trani, CA, Gomar, C, Moreno-Luqui, D, Ardaiz, N, Belsue, V, González-Gomariz, J, Ruiz-Guillamon, D, Risson, A, Zheng, YF, Huarte, E, Matos, I, Melero, I, Berraondo, P, Aranda, F "Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA".
 Theranostics. 16(7): 3541 - 3555. 2026. [doi:10.7150/thno.122132]
imagen
Arrizabalaga, L, Melero, I, Berraondo, P, Aranda, F "Routing immunomodulatory cytokine-encoded mRNAs to the omentum: turning an enemy into an ally in peritoneal metastasis".
 OncoImmunology. 14(1): 2510998 - 2510998. 2025. [doi:10.1080/2162402X.2025.2510998]
imagen
Llopiz, D, Silva, L, Ruiz, M, Castro-Alejos, C, Aparicio, B, Vegas, L, Infante, S, Santamaria, E, Sarobe, P "MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma".
 OncoImmunology. 14(1): 2473165 - 2473165. 2025. [doi:10.1080/2162402X.2025.2473165]
imagen
Gomar, C, Risson, A, Arrizabalaga, L, Ardaiz, N, Belsue, V, Gil-Korilis, A, Ahmadi-Erber, S, Schippers, T, Melero, I, Orlinger, KK, Aranda, F, Lauterbach, H, Berraondo, P "The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis".
 OncoImmunology. 14(1): 2520266 - 2520266. 2025. [doi:10.1080/2162402X.2025.2520266]
imagen
Anterior 1 2 3 4 5 6 7 8 9 10  ... Siguiente